608-09-3

Usage

Uses

Used in Pharmaceutical Industry:
(9H-PURIN-6-YLSULFANYL)-ACETIC ACID is used as a pharmaceutical intermediate for the development of drugs targeting various diseases. Its unique structure and potential biological activities make it a valuable building block in the synthesis of therapeutic agents.
Used in Organic Synthesis:
(9H-PURIN-6-YLSULFANYL)-ACETIC ACID serves as a key component in the preparation of other organic compounds. Its versatile chemical properties allow it to be incorporated into a wide range of molecules, contributing to the advancement of chemical research and the development of novel compounds with diverse applications.
Used in Biological Research:
(9H-PURIN-6-YLSULFANYL)-ACETIC ACID is utilized in biological studies to explore its potential interactions with biological systems. Its presence in various assays and experiments aids in understanding its role in biological processes and its potential as a therapeutic agent.
Overall, (9H-PURIN-6-YLSULFANYL)-ACETIC ACID is a multifaceted chemical with applications spanning across different industries, highlighting its significance in the fields of medicine, biology, and chemistry.

InChI:InChI=1/C7H6N4O2S/c12-4(13)1-14-7-5-6(9-2-8-5)10-3-11-7/h2-3,5H,1H2,(H,12,13)

Upstream product

• 50-44-2 6H-purine-6-thione 
• 79-11-8 chloroacetic acid 
• 157930-09-1 6-Mercaptopurine 
• 6941-72-6 6-(acetyl-O-ethylmercapto)purine 

Downstream Products

• 6312-66-9 6- purin 
• 4551-95-5 N⁶-(2-hydroxyethyl)adenine 
• 1928-81-0 6-(piperidin-1-yl)purine 

Relevant academic research and scientific papers

6-(acetyl-AA-sulfydryl)purine, and synthesis, activity and application thereof

The invention discloses 6-(acetyl-AA-sulfydryl)purine (wherein AA in the formula is Asp, Met and Ser residues) as shown in the specification, and a preparation method and antitumor activity thereof. The invention discloses application of 6-(acetyl-AA-sulf

Synthesis and biological evaluation of some 6-substituted purines

We report herein the synthesis and the in vitro antileishmanial evaluation of a series of 6-substituted purines. The most active compounds against Leishmania amazonensis promastigotes were 6-(3′-chloropropylthio)purine 2 (D.A. Benson, I. Karsch-Mizrachi, D.J. Lipman, J. Ostell, B.A. Rapp, D.L. Wheeler, Genbank. Nucleic Acids Res. 28 (2000) 15-18; E.V. Aleksandrova, P.M.I.E. Valashek, J. Med. Pharm. Chem. 35 (2001) 172-173), 6-(3′-(thioethylamine)propylthio)purine 5, 6-(α-aceticacidthio)purine 7 and 6-(6′-deoxy-1′-O-methyl-β-d-ribofuranose)purine 14 with an IC50 = 50, 50, 39 and 29 μM, respectively.

Synthesis of heterylthioalkanoic acids and their use for concentration of tungsten-containing ores

Methods for preparing a series of heterylthioalkanoic acids inclulding α-(indol-3-ylthio)propionic, α-(indol-3-ylthio)butyric, and pur-6-ylthioacetic acids were developed, and flotation properties of these compounds in concentration of tungsten-containing ores are studied.